Michael Foley Named Director of Tri-Institutional Therapeutics Discovery Institute

Add a Comment By Memorial Sloan-Kettering   |  Thursday, December 5, 2013 A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/michael-foley-named-director-of-tri-institutional-therapeutics-discovery-institute/" align="left"]

How does having diabetes affect my cancer treatment?

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, November 26, 2013 Memorial Sloan-Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/how-does-having-diabetes-affect-my-cancer-treatment/" align="left"]